NIH panel recommends combination HCV treatment.
Traynor
Kate
K
D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D016174:Hepacivirus / Q000235:genetics; D006526:Hepatitis C / Q000188:drug therapy* / Q000821:virology; D019698:Hepatitis C, Chronic / Q000188:drug therapy / Q000821:virology; D006801:Humans; D009316:National Institutes of Health (U.S.); D017410:Practice Guidelines as Topic; D014481:United States
D000998:Antiviral Agents